Published in Lab Business Week, April 3rd, 2005
The participants in the financing included international accredited investors. The company intends to use the proceeds of the Series A for, among other things, advancing the development of its two lead products, enhancing the product pipeline, building its intellectual property portfolio and expanding Abeille's management and advisory teams.
"We are pleased by the high caliber of our investors and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.